Favorable outcome under anticoagulant therapy in a high risk pregnancy case report and short review of the (recent) literature

The incidence of venous thromboembolism is significantly increased during pregnancy, recurrent venous thromboembolism being a serious complication because it is potentially life-threatening. According to recent ACCP guidelines, women with "high-risk" thrombophilias (e.g., homozygosity for...

Full description

Saved in:
Bibliographic Details
Published inMædica Vol. 7; no. 4; pp. 339 - 343
Main Authors Voican, Irina, Vladareanu, Prof Ana Maria, Onisai, Minodora, Nicolescu, Anca, Vladareanu, Prof Radu
Format Journal Article
LanguageEnglish
Published Romania Media Med Publicis 01.12.2012
Subjects
Case Reports
thromboembolism
pregnancy
anticoagulant therapy
Online AccessGet full text

Cover

More Information
Summary:The incidence of venous thromboembolism is significantly increased during pregnancy, recurrent venous thromboembolism being a serious complication because it is potentially life-threatening. According to recent ACCP guidelines, women with "high-risk" thrombophilias (e.g., homozygosity for factor V Leiden) who had a single prior episode of VTE treated with oral anticoagulants, should receive LMWH or UFH during pregnancy and puerperium, followed by resumption of long-term anticoagulants postpartum.We present the case of a young woman with a history of severe deep vein thrombosis of the inferior vena cava, occurring during oral contraceptive use. Subsequent investigation revealed homozygosity for Leiden mutation. She was treated with enoxaparin throughout gestation and 6 weeks postpartum and no complications appeared.
ISSN:1841-9038
2069-6116